key: cord-0974140-81aaakpx authors: Ramaiah, M. Janaki title: mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19 date: 2020-06-30 journal: Gene Rep DOI: 10.1016/j.genrep.2020.100765 sha: 11253641115c4991a458aa963b8abca95e3a98bb doc_id: 974140 cord_uid: 81aaakpx mTOR is a serine-threonine kinase and participates in cell proliferation, cellular metabolism was found to be activated during Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection and replication. During viral replication mTOR, downstream target genes such as ribosomal protein S6 kinase beta 1 (S6K1) and Eukaryotic translational initiation factor 4E-binding protein1 (4-E-BP1) are activated result in ribosome biosynthesis and efficient protein synthesis. In plasmacytoid dendritic cells (pDCs), mTOR plays a key role in the association of adapter protein myeloid differentiation primary response gene 88 (MyD88), Toll-like receptor 9 (TLR9) and interferon regulatory factor (IRF-7) leading to the transcriptional activation of type-I interferon (IFN) genes. Viruses also inactivate the interferon α (IFN-α) pathway by impairing the IRF-7 mediated activation of IFN-α gene transcription. Thus, mammalian target of rapamycin (mTOR) inhibitors can help in suppressing the early stages of viral infection and replication. Interestingly, the key tumor-suppressor p53 protein will undergo degradation by virus-encoded E3 ubiquitin ligase Ring-finger and CHY zinc-finger domain-containing 1 (RCHY1) leading to an increased viral survival in host cells. Thus, the mTOR inhibitors and p53 activators or microRNAs that functions as p53 and can target 3′-UTR of mTOR and RPS6KB1 might effectively inhibit viral replication in the human respiratory tract and lung cells. Recent studies have indicated about several mTOR inhibitors that are possible COVID-19 inhibitors (Table-1 restoration is interlinked with the translation machinery (Ristau et al., 2019) . Thus, small molecules that activate p53 may be of potential use in mediating host immune response. In invertebrates, the RNAi-mediated immunity the key pathway that operates during initial EZH2-mediated H3K27me3 inhibits ACE2 expression Virus Taxonomy: Classification and nomenclature of viruses) IXth Report of the International Committee on Taxonomy of Viruses Interspecies transmission and emergence of novel viruses: lessons from bats and birds Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks The mTOR Inhibitor Manassantin B Reveals A Crucial Role of mTORC2 Signaling in Epstein-Barr Virus Reactivation Upregulation of miR-101 during influenza A virus infection abrogates viral life cycle by targeting mTOR Pathway Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis The Human Papillomavirus Type 16 E6 Oncoprotein Activates mTORC1 Signaling and Increases Protein Synthesis Temporal Changes in cytokine/chemokine Profiles and Pulmonary Involvement in Severe Acute Respiratory Syndrome The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19 Induction of proinflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 SARS-CoV-2): anti-inflammatory strategies IL-6) expression and suppresses endothelial cell invasion stimulated by tumor cells Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated proinflammatory response in human vascular endothelial cells TOT signaling in growth and metabolism A SARS-CoV-2-Human protein-protein interaction map reveals drug targets and potential drug repurposing The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus Metformin in COVID19: A possible role beyond Diabetes LARP1 is major phosphorylation substrate of mTORC1 Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type-I interferon by Porcine reproductive respiratory syndrome virus Innate immunity to virus infection Innate immune pattern recognition: a cell biological perspective Interferons and viruses: an evolutionary arms race of molecular interactions Induction and function of type I and III interferon in response to viral infection Toll-like receptormediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI (3)K-mTOR-p70S6K pathway MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids MiR-99a anti-tumor activity in human breast cancer cells through targeting of mTOR expression p53-dependent noncoding RNA networks in chronic lymphocytic leukemia Tumor suppressor p53 meets microRNAs microRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cells MicroRNA-199a-5p Induced Autophagand Inhibits the Pathogenesis of Ankylosing Spondylitis by Modulating the mTOR Signaling via Directly Targeting Ras Homolog Enriched in Brain (Rheb) Tumor suppressor p53 meets microRNAs P53 regulates epithelialmesenchymal transition through microRNA targeting ZEB1 and ZEB2 MiR-15a and miR-16-1 cluster functions in human leukemia The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells MicroRNA-223-3p inhibits the angiogenesis of ischemic cardiac microvascular endothelial cells Via affecting RPS6KB1/hifα signal pathway MicroRNA-143 (miR-143) regulates cancer glycolysis Via Targeting Hexokinase 2 gene disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop Role of miR-143 targeting KRAS in colorectal tumorigenesis Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2-p53 Inhibitor in Clinical Development Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development The Nucleocapsid Protein of Coronaviruses Acts as a Viral Suppressor of RNA Silencing in Mammalian Cells MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63 Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity Modulation of microRNA processing by p53 An mTORC1-Mdm2-Drosha Axis for miRNA Biogenesis in Response to Glucose-And Amino Acid-Deprivation RNA interference-mediated intrinsic antiviral immunity in invertebrates RNAi and antiviral defense in Drosophila: setting up a systemic immune response Essential function in vivo for Dicer-2 in host defense against RNA viruses in drosophila Dicer-2 regulates resistance and maintains homeostasis against zika virus infection in Drosophila CD 8 (+) T cells; foot soldiers of the immune system MicroRNA directed program of cytotoxic CD8+ T cell differentiation Effector and memory CTL differentiation J o u r n a l P r e -p r o o f